Atlas Trials

Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study

Clinical trial NCT02563769 · COMPLETED

Trial details

NCT number
NCT02563769
Sponsor
Temple University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cocaine DependenceCocaine AddictionCocaine AbuseCocaine-Related Disorders
Start date
2016-10-24
Primary completion
2018-05-25
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.